Morphine IR & ER
ID: SPE2D2-25-R-0012Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/78c53b0ef7c343869d7b42f09056d828/view
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for the procurement of Morphine Immediate Release (IR) and Extended Release (ER) tablets under solicitation number SPE2D2-25-R-0012. This procurement aims to secure essential pharmaceutical products that are critical for military and healthcare operations. The solicitation outlines specific requirements for the morphine products, including dosages and quantities, and emphasizes compliance with various Federal Acquisition Regulation (FAR) clauses to ensure ethical conduct and transparency in the procurement process. Interested parties can reach out to Christopher Newman at christopher.newman@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries regarding submission procedures and requirements.

    Files
    Title
    Posted
    Morphine IR and ER SPE2D225R0012 Solicitation.pdf
    The document is a solicitation (SPE2D2-25-R-0012) from the Federal Government detailing procurement requirements for pharmaceutical products, specifically morphine tablets in various dosages and quantities. It outlines the contract's background, objectives, and compliance needs, emphasizing submission procedures via the Defense Logistics Agency Internet Bid Board System (DIBBS). Key details include instructions for offerors, a caution notice about submission methods, and mandatory clauses regarding business ethics and subcontracting for large businesses. The document mandates adherence to several Federal Acquisition Regulation (FAR) clauses, focusing on ethical conduct, subcontracting plans, performance assessments, and specific contract clauses relevant to commercial products and services. The solicitation indicates significant legal and ethical guidelines for contractors engaging in federal contracts, particularly regarding telecommunications equipment and supply chain security. This thoroughly structured solicitation serves to ensure compliance while promoting transparent procurement practices, particularly in sensitive sectors like pharmaceuticals essential for government operations.
    SPE2D225R00120001 released.pdf
    The document appears to be a corrupted or jumbled text containing numerous unintelligible characters, making it impossible to extract coherent information regarding government RFPs or grants. Consequently, no main topic, key ideas, or supporting details can be identified. It lacks a discernible structure or content that adheres to the expected format of formal government proposals, grants, or requests for proposals. As a result, attempts to summarize or analyze this file yield no useful or relevant insights. It is recommended that the document be reviewed or repaired to retrieve essential information pertaining to federal or state grant functions, RFP criteria, or related topics pertinent to government operations.
    Lifecycle
    Title
    Type
    Morphine IR & ER
    Solicitation
    Morphine IR & ER
    Currently viewing
    Presolicitation
    Similar Opportunities
    Trazodone - Solicitation
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for Trazodone HCL tablets in various dosages and bottle counts. This procurement aims to fulfill substantial pharmaceutical supply needs, emphasizing compliance with technical and quality requirements as outlined in the solicitation documents. The solicitation, identified as SPE2D2-26-R-0003, mandates electronic submissions via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Interested parties can reach out to Nancy Fernandez at nancy.fernandez@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Sertraline Tablets
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for the procurement of Sertraline Tablets in 25MG, 50MG, and 100MG dosages, with various bottle counts required over a base year and four option years. This solicitation, identified as SPE2D2-26-R-0002, is critical for ensuring the availability of this essential pharmaceutical, which is commonly used to treat depression and anxiety disorders among military personnel. Interested contractors must submit their offers electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) by the extended deadline of December 17, 2025, at 3:00 PM EST, and are encouraged to contact Christopher Newman or Jason Wray for further inquiries regarding the solicitation.
    Ondansetron Orally Disintegrating Tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT), specifically 4 MG and 8 MG tablets in various count bottles. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for treating nausea and vomiting in patients, and will be available for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be solicited in September 2025, although the DLA reserves the right to issue it earlier or later. Interested parties should direct inquiries to Nancy Fernandez at nancy.fernandez@dla.mil or call 445-737-0713, and are encouraged to set up automated notifications for any changes to the solicitation through the DLA Bid Board System and Sam.Gov.
    Metformin HCL
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is planning to issue a national requirements contract for Metformin HCL ER. The contract will establish a national supply source to provide Metformin HCL ER Tablets in various quantities and bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The solicitation will be posted on DLA Bid Board System (DIBBS) and Sam.gov. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is August 2021.
    Ibuprofen 400MG/600MG/800MG Tablets
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ibuprofen 400MG/600MG/800MG Tablets. The contract will establish a national supply source to provide the items for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is March of 2023.
    Metformin HCL ER
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is procuring Metformin HCL ER. Metformin HCL ER is a drug used to treat type 2 diabetes. This procurement is being conducted by DLA TROOP SUPPORT. For more information, contact Christopher Newman at christopher.newman@dla.mil or 2157372905.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    RapidRx IntelliCab 4 Drawer Cabinet
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking procurement for the RapidRx IntelliCab 4 Drawer Cabinet, a medical and surgical instrument essential for healthcare operations. This cabinet is designed to enhance the efficiency of medication management and distribution within military medical facilities. The procurement emphasizes the importance of reliable and advanced medical equipment in supporting troop health and operational readiness. Interested vendors can reach out to John Jackson at 301-619-4485 or via email at john.r.jackson@dla.mil, or contact Lucas Denault at 301-619-9888 for further inquiries regarding this opportunity.
    Reactive and Inactive Skin Decontamination Lotion
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking procurement for Reactive and Inactive Skin Decontamination Lotion (RSDL/ISDL). This contract involves the acquisition of specialized drugs and biologicals designed for decontaminating skin exposed to hazardous substances, which is critical for the safety and protection of military personnel in various operational environments. The opportunity is detailed in a redacted Justification and Approval document, indicating the importance of these products in maintaining troop readiness and safety. Interested vendors can reach out to Myrna I. Rodriguez at Myrna.Rodriguez@dla.mil or call 215.737.4711 for further information regarding this procurement.